Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure

This publication has 19 references indexed in Scilit:

• Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides
  Journal of the American College of Cardiology, 2005
• Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography
  European Journal of Heart Failure, 2003
• Prognostic Value of Myeloperoxidase in Patients with Chest Pain
  New England Journal of Medicine, 2003
• Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction
  Circulation, 2003
• Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction
  JAMA, 2002
• Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations
  BMJ, 2002
• Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes
  Circulation, 2002
• C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
  New England Journal of Medicine, 2000
• Biochemical detection of left-ventricular systolic dysfunction
  The Lancet, 1998
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997